Navigation Links
New Study Confers All Clear Status On Letrozole, Infertility Drug

Concerns about increased risk of birth defects associated with letrozole, a cost effective and an easy to use drug, commonly given for infertility treatment has been settled//. A new research has now established that the rate of birth defects associated with letrozole is very similar to that associated with clomiphene citrate, the first line treatment for infertility for more than 40 years that is associated with a low risk.

The researchers examined nearly 911 newborns who were treated for infertility with either clomiphene citrate or letrozole between 2001 and 2005.Babies of mothers treated with letrozole and clomiphene citrate had the same rate of incidence of birth defects.

The results of this study, which contradicts earlier studies linking letrozole to increased rates of inherited malformations, appear in the online version of Fertility and Sterility.

The drug letrozole has been increasingly used in infertility treatment in the recent years. No statistically significant difference in the incidence of minor/major birth defects or other chromosome abnormalities in newborns has been documented by the study. This highlights that letrozole can indeed be used in infertility treatment without increased birth defect risk to the fetus.

The reports of increased birth defects associated with use of the drug in earlier studies could be due to fault in the methodology. The previous studies compared the incidence of birth defects in children conceived through fertility treatments using letrozole and spontaneously conceived children. This equates to an oranges- and-apples comparison, as natural conception is always associated with a low risk of birth defects. In addition, previous studies had not taken care to include age-matched control and treatment groups.


'"/>




Page: 1

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: